IP Library Granted Patent US 7,674,249
Granted Patent B2
US 7,674,249 · App. 11/872,985 · Granted Mar 9, 2010

Gels with predetermined conductivity used in electroporation of tissue

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,674,249
App. No.
11/872,985
Granted
Mar 9, 2010
Kind
B2
Abstract

Gel compositions with adjusted conductivity are disclosed which compositions are used for directing reversible electroporation and irreversible electroporation of cells and tissue. The gel compositions are also used in a similar manner in order to carry out thermotherapy on cells and tissues.

Claims (40)

1. A method of carrying out electroporation of tissue, comprising:

inserting a gel into a patient by injection wherein the gel has a predetermined conductivity relative to surrounding tissue, the gel being semi-solid, elastic material comprised of matter in a colloidal state;

applying current across tissue in an amount so that cells of the tissue are subjected to electroporation;

wherein the conductivity of the gel is sufficiently below that of the surrounding tissue such that when current is applied substantially no current flows through the gel and the current is directed to a specific targeted area of tissue to be electroporated.

2. The method of claim 1 , wherein the gel is comprised of a therapeutically active drug.

3. The method of claim 1 , wherein the gel is a hydrogel comprised of water and solid phase polymer chains.

4. The method of claim 1 , wherein the conductivity of the gel is adjusted by incorporating a predetermined concentration of ions in the gel.

5. The method of claim 4 , wherein ions are derived from NaCl in the gel.

6. The method of claim 1 wherein the electroporation is reversible.

7. A method of carrying out electroporation of tissue, comprising:

inserting a gel into a patient by injection wherein the gel has a predetermined conductivity relative to surrounding tissue the gel being semi-solid, elastic material comprised of matter in a colloidal state;

applying current across tissue in an amount so that cells of the tissue are subjected to electroporation:

wherein the conductivity of the gel is substantially the same as that of surrounding tissue and when current is applied a homogeneous electrical field is applied and a specific area of targeted tissue is electroporated.

8. A method of carrying out electroporation of tissue, comprising:

inserting a gel into tissue in a patient by injection wherein the gel has a predetermined conductivity relative to tissue surrounding the gel, wherein the gel is a semi-solid, elastic material comprised of matter in a colloidal state;

applying current across tissue in an amount so that cells of the tissue are subjected to electroporation;

wherein the conductivity of the gel is predetermined by incorporating a known concentration of ions in the gel.

9. The method of claim 8 , wherein the ions are derived from NaCl dissolved in the gel and wherein the conductivity of the gel is sufficiently below that of the surrounding tissue such that when current is applied substantially no current flows through the gel and the current is directed to a specific targeted area of tissue to be electroporated.

10. The method of claim 8 , wherein the gel is a hydrogel comprised of water and solid phase polymer chains and wherein the conductivity of the gel is substantially the same as that of surrounding tissue and when current is applied a homogeneous electrical field is applied and a specific area of targeted tissue is electroporated.

11. The method of claim 8 , wherein the gel is comprised of a therapeutically active drug.

12. The method of claim 8 , wherein the electroporation is reversible.

13. A method of carrying out irreversible electroporation of tissue, comprising:

inserting a gel into a patient by injection wherein the gel has a predetermined conductivity relative to surrounding tissue the gel being semi-solid, elastic material comprised of matter in a colloidal state;

applying current across tissue in an amount so that cells of the tissue are subjected to irreversible electroporation;

wherein the conductivity of the gel is sufficiently below that of the surrounding tissue such that when current is applied substantially no current flows through the gel and the current is directed to a specific targeted area of tissue to be irreversibly electroporated.

14. The method of claim 13 , wherein the gel is comprised of a therapeutically active drug.

15. The method of claim 13 , wherein the gel is a hydrogel comprised of water and solid phase polymer chains.

16. The method of claim 13 , wherein the conductivity of the gel is adjusted by incorporating a predetermined concentration of ions in the gel.

17. The method of claim 16 , wherein ions are derived from NaCl in the gel.

18. A method of carrying out irreversible electroporation of tissue, comprising:

inserting a gel into a patient by injection wherein the gel has a predetermined conductivity relative to surrounding tissue the gel being semi-solid, elastic material comprised of matter in a colloidal state;

applying current across tissue in an amount so that cells of the tissue are subjected to irreversible electroporation;

wherein the conductivity of the gel is substantially the same as that of surrounding tissue and when current is applied a homogeneous electrical field is applied and a specific area of targeted tissue is irreversibly electroporated.

19. A method of carrying out irreversible electroporation of tissue, comprising:

inserting a gel into tissue in a patient by injection wherein the gel has a predetermined conductivity relative to tissue surrounding the gel, wherein the gel is a semi-solid, elastic material comprised of matter in a colloidal state;

applying current across tissue in an amount so that cells of the tissue are subjected to irreversible electroporation;

wherein the conductivity of the gel is predetermined by incorporating a known concentration of ions in the gel.

20. The method of claim 19 , wherein the ions are derived from NaCl dissolved in the gel and wherein the conductivity of the gel is sufficiently below that of the surrounding tissue such that when current is applied substantially no current flows through the gel and the current is directed to a specific targeted area of tissue to be irreversibly electroporated.

21. The method of claim 19 , wherein the gel is a hydrogel comprised of water and solid phase polymer chains and wherein the conductivity of the gel is substantially the same as that of surrounding tissue and when current is applied a homogeneous electrical field is applied and a specific area of targeted tissue is irreversibly electroporated.

22. The method of claim 19 , wherein the gel is comprised of a therapeutically active drug.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 11, 2010
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024826/0526 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Jul 23, 2008
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021289/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 3, 2008
From: IVORRA, ANTONI; RUBINSKY, BORIS
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 020754/0163 →
Continuity (2)
Provisional Application 6082958700 · Oct 16, 2006
Related Publication 20080214986A1 · Sep 4, 2008